Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
Status:
RECRUITING
Trial end date:
2026-02-28
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (MDD).